Clinical Trials Directory

Trials / Completed

CompletedNCT02567747

Vaccination Impact Against Pneumococcal Disease on Acute Otitis Media Morbidity in Colombian Children < 5 Years of Age

Impact of Vaccination Against Pneumococcal Disease on the Morbidity of Acute Otitis Media in Colombian Children < 5 Years of Age

Status
Completed
Phase
Study type
Observational
Enrollment
1 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
59 Months
Healthy volunteers
Accepted

Summary

The purpose of this study is to provide data on trends of morbidity due to Acute Otitis Media (AOM) (primary analysis) and morbidity and mortality due to pneumonia, and AOM related health care resources before and after the introduction of vaccination against pneumococcal disease within the Universal Mass Vaccination (UMV) in Colombia.

Conditions

Interventions

TypeNameDescription
OTHERData collectionData will be collected retrospectively for cases identified through RIPS\*/ DANE\*\* from 2008 until 2014 and through PAI\*\*\* from 2009 until 2014. \*Registro Individual de Prestación de Servicios de Salud (RIPS) database (Health Service Provider Individual Registration Database), Columbia. \*\*Departamento Administrativo Nacional de Estadística (DANE) database (The National Administrative Department of Statistics database), Columbia. \*\*\*Programa Ampliado de Immunizaciones (PAI) database (National Immunization Program database), Columbia.

Timeline

Start date
2015-10-01
Primary completion
2018-02-01
Completion
2018-02-23
First posted
2015-10-05
Last updated
2019-06-10

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT02567747. Inclusion in this directory is not an endorsement.

Vaccination Impact Against Pneumococcal Disease on Acute Otitis Media Morbidity in Colombian Children < 5 Years of Age (NCT02567747) · Clinical Trials Directory